On April 6, 2021, in connection with the IPO, Oleg Nodelman, Douglas Giordano, Nina Kjellson, Praveen Tipirneni, and Douglas E. Williams were appointed to the board of directors of the Panacea Acquisition Corp. II Effective April 6, 2021, Douglas Giordano, Praveen Tipirneni, and Douglas E. Williams were appointed to the Board’s Audit Committee, with Douglas Giordano serving as its chair. Nina Kjellson, Praveen Tipirneni and Douglas E. Williams were appointed to the Board’s Compensation Committee, with Nina Kjellson serving as its chair. Nina Kjellson, Praveen Tipirneni and Douglas E. Williams were appointed to the Board’s Nominating Committee, with Praveen Tipirneni serving as its chair.